688091 Shanghai Yizhong Pharmaceutical
- 40.43
- +0.72+1.81%
Shanghai Yizhong Pharmaceutical News
Express News | Shanghai Yizhong: Net profit of 29.178 million yuan in the first quarter decreased by 46.97% year on year
A-share innovative drug concept stocks declined, Kain Technology fell more than 17%
Gelonghui, April 10 | Kain Technology fell more than 17%, followed by Shanghai Yizhong, Pharmaceutical Kangchen, and Sailong Pharmaceutical.
Shanghai Yizhong (688091.SH) Performance Report: Net profit of 2023 was 163 million yuan, up 13.78% year-on-year
Gelonghui, Feb. 26: Shanghai Yizhong (688091.SH) announced the 2023 Annual Results Report. The company achieved operating revenue of 360 million yuan in 2023, an increase of 52.68% over the previous year. Net profit attributable to owners of the parent company was 163 million yuan, up 13.78% from the previous year; net profit attributable to owners of the parent company after deducting non-recurring profit and loss was 162 million yuan, an increase of 57.66% over the previous year.
Yizhong Pharmaceutical Starts Construction of Paclitaxel Polymer Micelles Production Facility; Shares Down 3%
Shanghai Yizhong Pharmaceutical (SHA:688091) started building a facility producing paclitaxel polymer micelles for injection after obtaining a construction license from the local government of China's
Express News | Shanghai Yizhong: Fund-raising Project Obtains Construction Permit for Construction Projects
Shanghai Yizhong (688091.SH): “Construction of 5 million injectable paclitaxel polymer micelles and supporting facilities per year” has obtained a construction license for construction projects
Gelonghui, Feb. 4: Shanghai Yizhong (688091.SH) announced that it has recently obtained a “Construction Permit” issued by the Fengxian District Construction and Management Committee, marking that the “construction of 5 million injectable paclitaxel polymer micelles and supporting facilities per year” has entered the construction phase.
Shanghai Yizhong (688091.SH), the main shareholder of Shanghai Kaibao (), did not reduce its holdings at the end of the holdings reduction period
According to the Zhitong Finance App, Shanghai Yizhong (688091.SH) announced that Shanghai Kaibao Pharmaceutical Co., Ltd. (“Shanghai Kaibao”), which holds more than 5% of the company's shares, has not reduced its holdings in the company, and the current holdings reduction period has expired.
Shanghai Yizhong (688091.SH) released the first three quarter results, net profit of 131 million yuan, an increase of 25.40% over the previous year
Shanghai Yizhong (688091.SH) released its report for the third quarter of 2023. The company achieved revenue of 2 in the first three quarters...
Yizhong Pharmaceutical's Plant Passes Good Manufacturing Practice Inspection of Shanghai's Drug Regulator
Shanghai Yizhong Pharmaceutical's (SHA:688091) production line for paclitaxel polymer micelles for injection passed the good manufacturing practice compliance inspection of the drug administration of
Some shareholders of Shanghai Yizhong (688091.SH) completed a reduction of 162,000 shares
Shanghai Yizhong (688091.SH) announced that company shareholders Li Feng, Li Xun, and Xu Yuexiang reduced their holdings of the company's shares by a total of 16...
Shanghai Yizhong (688091.SH): Director, Deputy General Manager, and Core Technician Sun Jing reduced her holdings by a total of 324,700 shares, and the time period for holdings reduction expires
Glonghui, Oct. 13, 丨 Shanghai Yizhong (688091.SH) announced that the company recently received the “Notification Letter on the Expiration of the Plan and the Results of the Reduction of Holdings” from Ms. Sun Jing, director, deputy general manager and core technician. As of October 9, 2023, Ms. Sun Jing had reduced her holdings of the company's shares by 324,700 shares through centralized bidding, accounting for 0.21% of the company's total share capital. The holdings reduction period has expired.
Shanghai Yizhong (688091.SH) will list and circulate approximately 1,582,800 restricted shares from September 11
According to the Zhitong Finance App, Shanghai Yizhong (688091.SH) announced that the restricted shares currently listed are the company's initial public offering of strategic placement restricted shares. The limited sale period is 24 months from the date the company's shares are listed. The number of shares that have been lifted from sale restrictions and applied for listing and circulation is about 1,582,800 shares, accounting for 1% of the company's total share capital. The number of shareholders involved is 1. This portion of the restricted shares will be listed and distributed from September 11, 2023.
Shanghai Yizhong (688091) Company Incident Review Report: Guidelines to Strengthen the Influence of Paclitaxel Micelles and Steady Revenue Growth
Incident Shanghai Yizhong Co., Ltd. issued a performance announcement for the semi-annual report of 2023: revenue for the first half of 2023 was 2000.4 million yuan, up 178.88% year on year; net profit of Gimu was 104.1 million yuan, up 70.73% year on year
Shanghai Yizhong (688091.SH) plans to launch an incentive plan for 3 million restricted shares
Shanghai Yizhong (688091.SH) disclosed the 2023 Restricted Stock Incentive Plan (Draft) to 18...
Shanghai Yizhong: Net profit is expected to increase 64% to 80% year-on-year in the first half of the year
On July 23丨Shanghai Yizhong announced that the company expects to achieve revenue of 200 million yuan to 210 million yuan in the first half of the year, with a value of 71.808 million yuan for the same period last year, an increase of 178.28% to 192.19% over the previous year. Net profit from the original mother is estimated to be 100 million yuan to 110 million yuan, with a value of 609.792 million yuan for the same period last year, an increase of 63.99% to 80.39% over the previous year.
Shanghai Yizhong (688091.SH) is forecasted to increase net profit of 100 million to 110 million yuan for the half year, up 63.99% to 80.39% year on year
According to the Zhitong Finance App, Shanghai Yizhong (688091.SH) released its 2023 semi-annual results forecast and expects to achieve operating income of 200 million yuan to 210 million yuan for the half year of 2023, with a value of 71.808 million yuan for the same period last year, an increase of 178.28% to 192.19% over the previous year. The company expects to achieve net profit attributable to owners of the parent company of 100 million yuan to 110 million yuan in the half year of 2023, with a value of 69.992 million yuan for the same period last year, an increase of 63.99% to 80.39% over the previous year. The company expects to achieve deductions attributable to owners of the parent company in the half year of 2023
Some shareholders of Shanghai Yizhong (688091.SH) reduced their holdings by a total of 132,700 shares
According to the Zhitong Finance App, Shanghai Yizhong (688091.SH) announced that the company's shareholders Li Feng, Li Xun, and Xu Yuexiang reduced their holdings of the company's shares by a total of 132,700 shares, accounting for 0.08% of the total share capital. The time for this holdings reduction plan is already over half.
Shanghai Yizhong (688091.SH): More than half of the time to reduce their holdings, Li Xun and Xu Yuexiang have reduced their holdings by a total of 0.08%
GLONGHUI, July 19丨Shanghai Yizhong (688091.SH) announced that as of July 19, 2023, Li Xun had reduced his holdings of the company's shares by a total of 21,329 shares through centralized bidding, accounting for 0.01% of the company's total share capital; Xu Yuexiang has reduced his holdings by 111,340 shares of the company's total share capital through centralized bidding, accounting for 0.07% of the company's total share capital; Li Feng has not reduced their holdings; the shareholders mentioned above have not reduced their holdings during the window period, etc. Halfway through the time of this holdings reduction plan, the implementation of the holdings reduction plan has not yet been completed.
Sun Jing, director of Shanghai Yizhong (688091.SH), reduced the company's holdings by a total of 249,700 shares
According to the Zhitong Finance App, Shanghai Yizhong (688091.SH) announced that as of July 7, Sun Jing, director, deputy general manager, and core technician, had reduced the company's shares by a total of 249,700 shares through centralized bidding, accounting for 0.16% of the company's total share capital. The amount of holdings reduced in this plan has been reduced by more than half, and the implementation of the holdings reduction plan has not yet been completed.
Shanghai Yizhong (688091.SH): Sun Jing, deputy general manager and core technician, has reduced his holdings by more than half
On July 7, 2023, GLONGHUI | Shanghai Yizhong (688091.SH) announced that on July 7, 2023, the company received the “Notice on the Implementation Status of the Holding Reduction Plan and the Amount of Holding Reduction” issued by Ms. Sun Jing, director, deputy general manager and core technician. As of July 7, 2023, Ms. Sun Jing had reduced her holdings of the company's shares by a total of 249,700 shares through centralized bidding, accounting for 0.16% of the company's total share capital. The amount of holdings reduced in this plan has been reduced by more than half, and the implementation of the holdings reduction plan has not yet been completed.
Analysis
Price Target
No Data
